loading
前日終値:
$13.01
開ける:
$13.03
24時間の取引高:
211.91K
Relative Volume:
0.51
時価総額:
$692.04M
収益:
$217.25M
当期純損益:
$-50.92M
株価収益率:
-13.14
EPS:
-1
ネットキャッシュフロー:
$-100.85M
1週間 パフォーマンス:
+1.31%
1か月 パフォーマンス:
-13.15%
6か月 パフォーマンス:
-34.46%
1年 パフォーマンス:
-46.95%
1日の値動き範囲:
Value
$12.70
$13.22
1週間の範囲:
Value
$12.46
$13.71
52週間の値動き範囲:
Value
$11.70
$26.36

Prothena Corporation Plc Stock (PRTA) Company Profile

Name
名前
Prothena Corporation Plc
Name
セクター
Healthcare (1166)
Name
電話
011-353-1-236-2500
Name
住所
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Name
職員
0
Name
Twitter
@ProthenaCorp
Name
次回の収益日
2025-02-18
Name
最新のSEC提出書
Name
PRTA's Discussions on Twitter

PRTA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PRTA
Prothena Corporation Plc
13.14 692.04M 217.25M -50.92M -100.85M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-20 開始されました Chardan Capital Markets Buy
2024-01-30 ダウングレード BofA Securities Buy → Neutral
2023-12-12 開始されました Deutsche Bank Buy
2023-04-24 開始されました SVB Securities Outperform
2023-01-27 開始されました Piper Sandler Overweight
2022-11-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2022-09-28 アップグレード BofA Securities Neutral → Buy
2021-11-19 開始されました JMP Securities Mkt Outperform
2021-06-18 アップグレード BofA Securities Underperform → Neutral
2021-06-08 繰り返されました Oppenheimer Outperform
2021-05-26 開始されました Citigroup Buy
2021-02-26 アップグレード RBC Capital Mkts Sector Perform → Outperform
2021-02-12 アップグレード Jefferies Hold → Buy
2021-02-02 アップグレード BTIG Research Neutral → Buy
2020-12-07 開始されました H.C. Wainwright Buy
2020-07-09 アップグレード Oppenheimer Perform → Outperform
2019-11-19 アップグレード Evercore ISI In-line → Outperform
2018-05-21 ダウングレード Barclays Equal Weight → Underweight
2018-04-23 ダウングレード Jefferies Buy → Hold
2018-04-05 繰り返されました Barclays Overweight
2017-11-20 ダウングレード Wedbush Outperform → Neutral
2017-09-29 繰り返されました BTIG Research Buy
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-08-17 開始されました Evercore ISI Outperform
2017-07-11 開始されました Jefferies Buy
2017-04-12 開始されました Cantor Fitzgerald Overweight
2017-04-12 開始されました Piper Jaffray Overweight
2017-03-02 開始されました Instinet Buy
2016-12-21 開始されました SunTrust Buy
2016-11-03 開始されました Deutsche Bank Buy
2016-08-04 繰り返されました Barclays Overweight
2016-05-13 開始されました Barclays Overweight
2016-02-19 繰り返されました Wedbush Outperform
2016-01-21 開始されました Credit Suisse Outperform
すべてを表示

Prothena Corporation Plc (PRTA) 最新ニュース

pulisher
Mar 26, 2025

Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World

Mar 26, 2025
pulisher
Mar 23, 2025

Amundi Has $28,000 Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

(PRTA) Technical Data - Stock Traders Daily

Mar 22, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Has $2.08 Million Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Brokerages Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $55.00 - Defense World

Mar 20, 2025
pulisher
Mar 17, 2025

Zacks Research Has Positive Outlook of Prothena Q1 Earnings - Defense World

Mar 17, 2025
pulisher
Mar 16, 2025

Insider Sell: Chief Medical Officer Hideki Garren Sells 2,000 Sh - GuruFocus.com

Mar 16, 2025
pulisher
Mar 15, 2025

Zacks Research Weighs in on Prothena FY2027 Earnings - Defense World

Mar 15, 2025
pulisher
Mar 12, 2025

Trend Tracker for (PRTA) - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Recent Analysts’ Ratings Changes for Prothena (PRTA) - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Rhumbline Advisers Boosts Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World

Mar 07, 2025
pulisher
Mar 04, 2025

Prothena Co. plc (NASDAQ:PRTA) Shares Purchased by Handelsbanken Fonder AB - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Prothena Corporation: Multiple Failures Make It Risky (NASDAQ:PRTA) - Seeking Alpha

Mar 03, 2025
pulisher
Feb 28, 2025

Prothena (NASDAQ:PRTA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

PROTHENA CORP PUBLIC LTD CO SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 25, 2025

Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus - MSN

Feb 25, 2025
pulisher
Feb 25, 2025

Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Prothena (NASDAQ:PRTA) Rating Increased to Hold at StockNews.com - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga

Feb 24, 2025
pulisher
Feb 24, 2025

Prothena’s (PRTA) “Buy” Rating Reiterated at HC Wainwright - Defense World

Feb 24, 2025
pulisher
Feb 24, 2025

Prothena’s (PRTA) “Buy” Rating Reiterated at Chardan Capital - Defense World

Feb 24, 2025
pulisher
Feb 23, 2025

Analysts Set Prothena Co. plc (NASDAQ:PRTA) PT at $46.50 - Defense World

Feb 23, 2025
pulisher
Feb 23, 2025

Cantor Fitzgerald Reaffirms “Overweight” Rating for Prothena (NASDAQ:PRTA) - Defense World

Feb 23, 2025
pulisher
Feb 23, 2025

Royal Bank of Canada Has Lowered Expectations for Prothena (NASDAQ:PRTA) Stock Price - Defense World

Feb 23, 2025
pulisher
Feb 22, 2025

Prothena Corporation plc (NASDAQ:PRTA) Just Released Its Yearly Earnings: Here's What Analysts Think - Simply Wall St

Feb 22, 2025
pulisher
Feb 21, 2025

Prothena Corporation plc (NASDAQ:PRTA) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 21, 2025
pulisher
Feb 21, 2025

RBC Cuts Price Target on Prothena to $20 From $24, Keeps Sector Perform, Speculative Risk - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Prothena Corporation (NASDAQ: PRTA) Gears Up for Transformational 2025 with Key Clinical Milestones - Pradesh Tak

Feb 21, 2025
pulisher
Feb 21, 2025

Earnings call transcript: Prothena's Q4 2024 results highlight innovation By Investing.com - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ... - Yahoo Finance

Feb 21, 2025
pulisher
Feb 20, 2025

Earnings call transcript: Prothena's Q4 2024 results highlight innovation - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Prothena: Q4 Earnings Snapshot -February 20, 2025 at 04:23 pm EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights - Business Wire

Feb 20, 2025
pulisher
Feb 18, 2025

(PRTA) Trading Advice - Stock Traders Daily

Feb 18, 2025
pulisher
Feb 18, 2025

Prothena Corporation PLC expected to post a loss of $1.04 a shareEarnings Preview - TradingView

Feb 18, 2025
pulisher
Feb 17, 2025

Kuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law Firm - EIN News

Feb 17, 2025
pulisher
Feb 17, 2025

The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

Merck KGaA bids for SpringWorks (SWTX), Evolus (EOLS) receives FDA nod & Prothena (PRTA) struggles - substack.com

Feb 17, 2025
pulisher
Feb 13, 2025

Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - Business Wire

Feb 13, 2025
pulisher
Feb 13, 2025

Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight - GlobeNewswire Inc.

Feb 13, 2025
pulisher
Feb 13, 2025

Focused Wealth Management Inc Makes New Investment in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Critical Survey: Prothena (NASDAQ:PRTA) vs. Annexon (NASDAQ:ANNX) - Defense World

Feb 13, 2025
pulisher
Feb 13, 2025

Prothena (PRTA) to Release Quarterly Earnings on Thursday - Defense World

Feb 13, 2025
pulisher
Feb 12, 2025

Prothena (NASDAQ:PRTA) Given New $62.00 Price Target at Oppenheimer - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

KALA BIO (NASDAQ:KALA) and Prothena (NASDAQ:PRTA) Financial Survey - Defense World

Feb 12, 2025
pulisher
Feb 10, 2025

Prothena (NASDAQ:PRTA) Price Target Raised to $62.00 - Defense World

Feb 10, 2025
pulisher
Feb 08, 2025

Form S-8Securities to be offered to employees in employee benefit plans - br.ADVFN.com

Feb 08, 2025
pulisher
Feb 08, 2025

Learn to Evaluate (PRTA) using the Charts - Stock Traders Daily

Feb 08, 2025
pulisher
Feb 07, 2025

Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings) - Benzinga

Feb 07, 2025

Prothena Corporation Plc (PRTA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):